Latham & Watkins has been chosen as M&A Firm of the Year, Licensing & Collaboration Firm of the Year, and France Firm of the Year, while partner Eveline Van Keymeulen was recognized as Advisory Lawyer of the Year and won Impact Deal of the Year at the prestigious Europe LMG Life Sciences Awards 2021. The firm saw off strong competition from firms who have performed exceptionally at both local and national levels.
LMG Life Sciences Awards Researcher John Harrison said of Latham’s wins: “Latham & Watkins has been advising on a vast array of the top M&A transactions in the European life sciences sector. They have also been advising start-ups on equity investments from some of the largest life sciences companies and were involved with some of the most complex licensing agreements for treatments of cancer, rare diseases and COVID-19.”
“Eveline Van Keymeulen joined the firm as a partner and is well-known for advising companies on key strategic policy and legal issues relating to EU regulatory frameworks. A major highlight from 2020 for Eveline was her success before the European Court of Justice on behalf of KanaVape. This impactful work saw a landmark decision, declaring CBD to not be classified as a narcotic. A decision that goes against the previously held view by the European Commission. Eveline’s successful argument has opened up the use of CBD throughout the EU.”
The LMG Life Sciences Europe Virtual Awards 2021 celebrate firms and attorneys on the forefront of legal work in life sciences across a broad spectrum of associated practice areas. Supported by its sister publications, the Life Sciences Awards follow a comprehensive research process of case evidence, client feedback and peer interviews to highlight the firms, individuals and notable matters of the year.